Johnson & Johnson (JNJ) outlines potential NYSE stock sale in Form 144

Rhea-AI Filing Summary

Johnson & Johnson submitted a Form 144 notice covering potential sales of its common stock through J.P. Morgan Securities LLC on the NYSE. The disclosure also lists issuer transactions in the past three months related to executive compensation, including 4,625 shares of common stock on 02/15/2026 and 43,855 shares on 02/13/2026.

Key Figures

Executive compensation shares: 4,625 shares Executive compensation shares: 43,855 shares

2 metrics

Executive compensation shares 4,625 shares Common stock transaction dated 02/15/2026 classified as executive compensation by the issuer

Executive compensation shares 43,855 shares Common stock transaction dated 02/13/2026 classified as executive compensation by the issuer

Key Terms

Form 144, executive compensation, Issuer

3 terms

Form 144 regulatory

"144: Filer Information 144: Issuer Information 144: Securities Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

executive compensation financial

"Common Stock | 02/15/2026 | Executive compensation | Issuer"

Payments and benefits given to a company's top leaders — including base salary, cash bonuses, stock awards, options and retirement or perquisites — designed to compensate and motivate them. Investors care because these packages affect a company’s costs, influence executives’ decisions and signal how well management’s interests line up with shareholders’; like a captain’s contract, the structure of pay can encourage safe navigation toward long-term gains or risky short-term moves that hurt returns.

Issuer regulatory

"Common Stock | 02/13/2026 | Executive compensation | Issuer"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/05/2026 - 06:08 PM Accepted by SEC EDGAR 08/05/2026 - 06:07 PM Learn about SEC filing dates

FAQ

What does Johnson & Johnson (JNJ) report in this Form 144?

Johnson & Johnson reports a planned sale of common stock under Form 144. The notice identifies J.P. Morgan Securities LLC as the broker and indicates that the stock is listed on the NYSE.

Which broker is involved in the Johnson & Johnson (JNJ) Form 144 notice?

The Form 144 lists J.P. Morgan Securities LLC, located at 270 Park Avenue, New York, as the broker handling potential common stock sales on the NYSE.

What recent executive compensation transactions does JNJ disclose?

Johnson & Johnson discloses two issuer transactions for executive compensation: 4,625 shares of common stock dated 02/15/2026 and 43,855 shares of common stock dated 02/13/2026.

Are the recent Johnson & Johnson (JNJ) share transactions issuer-related?

Yes. The past three months’ entries identify the Issuer as the party for two executive compensation grants involving 4,625 and 43,855 common shares in February 2026.

On which exchange are the Johnson & Johnson (JNJ) shares in the Form 144 listed?

The common stock referenced in the Form 144 is listed on the NYSE. The notice ties the potential sale of Johnson & Johnson common shares to trading on this exchange.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 270 Park Avenue, 10th Floor New York NY 10017	48480	12359006	2409898597	08/05/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/15/2026	Executive compensation	Issuer			4625	02/15/2026	Compensation
Common Stock	02/13/2026	Executive compensation	Issuer			43855	02/13/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)